Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
Costs and benefits of dose-dense chemotherapy scheduling in Hong Kong Chinese patients with primary breast cancer Proceeding/Conference:ASCO Annual Meeting Proceedings | 2007 | ||
KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma Proceeding/Conference:Annals of Oncology | 2016 | ||
Single-nucleotide polymorphism (SNP) of excision repair cross complementation group 1 (ERCC1) in nasopharynx cancer (NPC): A companion biomarker study to Hong Kong NPC Study Group 0502 trial Proceeding/Conference:American Society of Clinical Oncology (ASCO) Annual Meeting 2014 | 2014 |